Lyme disease aftercare: new insights into persistent symptoms

Study explores the causes of persistent symptoms after Lyme borreliosis (LB) treatment, revealing that factors like social and physical functioning, psychological distress, and comorbidities are key determinants.

Otsuka, ShapeTX to develop gene therapies for eye diseases

The companies will develop gene therapies for ocular diseases under the new deal. Credit: elenavolf / Shutterstock.com. Otsuka Pharmaceutical has entered a multi-target partnership with

September 8, 2023

Rymedi Raises $9M for Blockchain-Secured Data Platform

What You Should Know: Rymedi, a healthcare data exchange platform with advanced blockchain security, has announced a Series A totaling $9 million with plans to expand the

October 31, 2023

FDA rejects Novo Nordisk’s once-weekly insulin after questioning risks

Novo Nordisk’s once-weekly insulin has been turned down by the FDA, and the Danish pharma likely won’t be refiling until next year. The FDA rejection

July 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.